• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

慢性丙型肝炎患者在无干扰素直接抗病毒治疗持续病毒学应答后，其急诊科就诊率和住院率降低（2014-2018 年）。

Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014-2018).

机构信息

Department of Gastroenterology and Hepatology, Henry Ford Health System, Detroit Michigan, USA.

Wayne State University School of Medicine, Detroit Michigan, USA.

出版信息

Clin Infect Dis. 2022 Oct 12;75(8):1453-1456. doi: 10.1093/cid/ciac124.

DOI:10.1093/cid/ciac124
PMID:35147184
Abstract

We compared rates of emergency department visits and hospitalizations between patients with hepatitis C virus who achieved sustained virological response after direct-acting antiviral therapy (case patients) and matched controls. Among 3049 pairs, case patients demonstrated lower rates of liver-related emergency department visits (P = .01) than controls; all-cause and liver-related hospitalization rates and number of hospitalized days were also lower in case patients (P < .001).

摘要

我们比较了直接作用抗病毒治疗后获得持续病毒学应答的丙型肝炎病毒患者（病例患者）和匹配对照者的急诊就诊率和住院率。在 3049 对患者中，病例患者的肝相关急诊就诊率较低（P=0.01）；病例患者的全因和肝相关住院率以及住院天数也较低（P<0.001）。

相似文献

1
Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014-2018).慢性丙型肝炎患者在无干扰素直接抗病毒治疗持续病毒学应答后，其急诊科就诊率和住院率降低（2014-2018 年）。
Clin Infect Dis. 2022 Oct 12;75(8):1453-1456. doi: 10.1093/cid/ciac124.
2
α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response.干扰素治疗后甲胎蛋白水平可预测病毒学持续应答患者肝纤维化的消退情况。
J Gastroenterol Hepatol. 2016 May;31(5):1001-8. doi: 10.1111/jgh.13245.
3
Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.格鲁吉亚全国丙型肝炎消除规划中接受索磷布韦为基础联合治疗的慢性丙型肝炎患者的治疗结局。
BMC Infect Dis. 2020 Jan 10;20(1):30. doi: 10.1186/s12879-019-4741-5.
4
Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free.慢性丙型肝炎患者直接作用抗病毒药物无干扰素治疗的健康相关生活质量和疲劳。
PLoS One. 2020 Aug 19;15(8):e0237005. doi: 10.1371/journal.pone.0237005. eCollection 2020.
5
Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.直接作用抗病毒治疗在退伍军人管理局治疗初治慢性 HCV 基因型 1 感染患者中的成本效益。
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1503-10. doi: 10.1016/j.cgh.2013.05.014. Epub 2013 May 22.
6
The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C.聚乙二醇干扰素/利巴韦林治疗地中海贫血合并慢性丙型肝炎患者的疗效及对输血需求的影响。
J Formos Med Assoc. 2018 Jan;117(1):14-23. doi: 10.1016/j.jfma.2017.10.001. Epub 2017 Oct 31.
7
'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.终末期肾病患者使用丙型肝炎病毒直接抗病毒药物的“真实世界”经验。
Int J Artif Organs. 2018 Jul;41(7):363-370. doi: 10.1177/0391398818763478. Epub 2018 Mar 27.
8
Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents.检测埃及患者在直接抗病毒药物治疗后获得持续病毒学应答者中的隐匿性丙型肝炎病毒感染。
Asian Pac J Cancer Prev. 2022 Sep 1;23(9):2965-2971. doi: 10.31557/APJCP.2022.23.9.2965.
9
Territory-wide population-based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong Kong.全港人口为基础的慢性丙型肝炎感染研究及对香港消除肝炎的启示。
Liver Int. 2018 Nov;38(11):1911-1919. doi: 10.1111/liv.13926. Epub 2018 Jul 30.
10
Factors That Influence the Virological Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin.聚乙二醇干扰素和利巴韦林治疗的慢性丙型肝炎患者病毒学应答的影响因素
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Mar 1;38(1):25-33. doi: 10.1515/prilozi-2017-0003.

引用本文的文献

1
The impact of expanded access to direct acting antivirals for Hepatitis C virus on patient outcomes in Canada.加拿大扩大直接作用抗病毒药物获取途径对丙型肝炎病毒患者结局的影响。
PLoS One. 2023 Aug 8;18(8):e0284914. doi: 10.1371/journal.pone.0284914. eCollection 2023.
2
Temporal Trends in Hepatitis C-Related Hospitalizations, United States, 2000-2019.2000-2019 年美国丙型肝炎相关住院治疗的时间趋势。
Clin Infect Dis. 2023 Dec 15;77(12):1668-1675. doi: 10.1093/cid/ciad425.